Research ArticleClinical Studies
Initiation of Systemic Therapy During the Last 30 Days of Life in Patients With Metastatic Castration-resistant Prostate Cancer
CARSTEN NIEDER, ELLINOR HAUKLAND, BÅRD MANNSÅKER, ADAM PAWINSKI, ROSALBA YOBUTA and JAN NORUM
Anticancer Research January 2019, 39 (1) 335-340; DOI: https://doi.org/10.21873/anticanres.13116
CARSTEN NIEDER
1Department of Clinical Medicine, Faculty of Health Sciences, UiT – The Arctic University of Norway, Tromsø, Norway
2Department of Oncology and Palliative Medicine, Nordland Hospital, Bodø, Norway
ELLINOR HAUKLAND
2Department of Oncology and Palliative Medicine, Nordland Hospital, Bodø, Norway
BÅRD MANNSÅKER
2Department of Oncology and Palliative Medicine, Nordland Hospital, Bodø, Norway
ADAM PAWINSKI
2Department of Oncology and Palliative Medicine, Nordland Hospital, Bodø, Norway
ROSALBA YOBUTA
2Department of Oncology and Palliative Medicine, Nordland Hospital, Bodø, Norway
JAN NORUM
1Department of Clinical Medicine, Faculty of Health Sciences, UiT – The Arctic University of Norway, Tromsø, Norway
3Department of Surgery, Finnmark Hospital, Hammerfest, Norway
In this issue
Anticancer Research
Vol. 39, Issue 1
January 2019
Initiation of Systemic Therapy During the Last 30 Days of Life in Patients With Metastatic Castration-resistant Prostate Cancer
CARSTEN NIEDER, ELLINOR HAUKLAND, BÅRD MANNSÅKER, ADAM PAWINSKI, ROSALBA YOBUTA, JAN NORUM
Anticancer Research Jan 2019, 39 (1) 335-340; DOI: 10.21873/anticanres.13116
Jump to section
Related Articles
- No related articles found.